
The primary objective of this study was to identify intravenous regimens of zzso that would mimic the systemic exposure obtained after the current zzso oral administration of zzso After determination of an intravenous dose that 6 subjects with advanced cancer could zzso another 26 subjects were randomly assigned to receive 3 consecutive zzso regimens of zzso with different treatment zzso a zzso zzso intravenous infusion, zzso oral administration twice daily, and a zzso continuous intravenous zzso The systemic exposure to zzso was comparable among these 3 zzso The plasma zzso profile of zzso intravenous infusion more closely resembled the oral administration than did the continuous zzso zzso is a zzso zzso for zzso with zzso of the zzso zzso greatly exceeding the parent compound after oral and intravenous zzso Analysis of plasma zzso indicated that zzso also zzso zzso and loss of the zzso zzso 

